Copyright
©The Author(s) 2021.
World J Diabetes. Nov 15, 2021; 12(11): 1875-1893
Published online Nov 15, 2021. doi: 10.4239/wjd.v12.i11.1875
Published online Nov 15, 2021. doi: 10.4239/wjd.v12.i11.1875
Figure 3 Expression of profilin-1 in the thoracic aortas of advanced glycation end products-injected rats.
A-C: Western blot analysis and real-time PCR detection of the expression of the profilin-1 protein and mRNA, respectively, in the thoracic aorta. n = 3, aP < 0.05 compared with the control group, bP < 0.01 compared with the control group; D: Immunohistochemical staining revealing the expression of the profilin-1 protein in the thoracic aorta. Under a microscope at 200 × magnification, the profilin-1 protein was stained brown using the SABC immunohistochemical method, n = 3. AGEs: Advanced glycation end products.
- Citation: Xiao ZL, Ma LP, Yang DF, Yang M, Li ZY, Chen MF. Profilin-1 is involved in macroangiopathy induced by advanced glycation end products via vascular remodeling and inflammation. World J Diabetes 2021; 12(11): 1875-1893
- URL: https://www.wjgnet.com/1948-9358/full/v12/i11/1875.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i11.1875